RVMD
Price:
$153.87
Market Cap:
$32.71B
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic ar...[Read more]
Industry
Biotechnology
IPO Date
2020-02-13
Stock Exchange
NASDAQ
Ticker
RVMD
According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.43B. This represents a change of 162.95% compared to the average of 12.33B of the last 4 quarters.
The mean historical Enterprise Value of Revolution Medicines, Inc. over the last ten years is 3.75B. The current 32.43B Enterprise Value has changed 86.42% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Enterprise Value was at its highest in in the March 2026 quarter at 18.98B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
3.75B
Median
1.82B
Minimum
984.63M
Maximum
14.92B
Discovering the peaks and valleys of Revolution Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.79%
Maximum Annual Enterprise Value = 14.92B
Minimum Annual Increase = -30.19%
Minimum Annual Enterprise Value = 984.63M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 14.92B | 115.29% |
| 2024 | 6.93B | 162.79% |
| 2023 | 2.64B | 44.62% |
| 2022 | 1.82B | 1.82% |
| 2021 | 1.79B | -30.19% |
| 2020 | 2.57B | 147.26% |
| 2019 | 1.04B | 5.36% |
| 2018 | 984.63M | -5.78% |
The current Enterprise Value of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.16B
5-year avg
5.62B
10-year avg
3.75B
Revolution Medicines, Inc.’s Enterprise Value is greater than BridgeBio Pharma, Inc. (15.59B), greater than Ionis Pharmaceuticals, Inc. (13.98B), greater than Exelixis, Inc. (13.30B), greater than Moderna, Inc. (19.19B), greater than BioMarin Pharmaceutical Inc. (10.03B), greater than Summit Therapeutics Inc. (10.80B), greater than Ascendis Pharma A/S (11.98B), greater than Roivant Sciences Ltd. (20.29B), greater than Atrium Therapeutics, Inc. (-53572208.00), greater than Madrigal Pharmaceuticals, Inc. (11.20B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 15.59B | $13.08B | |
| 13.98B | $12.11B | |
| 13.30B | $13.35B | |
| 19.19B | $19.80B | |
| 10.03B | $10.81B | |
| 10.80B | $10.86B | |
| 11.98B | $13.54B | |
| 20.29B | $21.61B | |
| -53572208.00 | $211.60M | |
| 11.20B | $11.08B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Revolution Medicines, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Revolution Medicines, Inc. (RVMD)?
What is the 3-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?
What is the 5-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?
How does the current Enterprise Value for Revolution Medicines, Inc. (RVMD) compare to its historical average?